REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $925,000 | -34.4% | 700,608 | +3.8% | 0.00% | – |
| Q3 2016 | $1,410,000 | +29.7% | 674,848 | 0.0% | 0.00% | – |
| Q2 2016 | $1,087,000 | +107.0% | 674,848 | +24.6% | 0.00% | – |
| Q1 2016 | $525,000 | -19.8% | 541,611 | 0.0% | 0.00% | – |
| Q4 2015 | $655,000 | -83.7% | 541,611 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $4,024,000 | -12.0% | 541,611 | -15.3% | 0.00% | 0.0% |
| Q2 2015 | $4,573,000 | -37.5% | 639,606 | -24.9% | 0.00% | 0.0% |
| Q1 2015 | $7,315,000 | -13.7% | 851,532 | +0.2% | 0.00% | 0.0% |
| Q4 2014 | $8,474,000 | +2.4% | 849,971 | +1.7% | 0.00% | 0.0% |
| Q3 2014 | $8,278,000 | -40.3% | 836,154 | +4.3% | 0.00% | -50.0% |
| Q2 2014 | $13,875,000 | -2.0% | 801,995 | +0.5% | 0.00% | 0.0% |
| Q1 2014 | $14,160,000 | +8.4% | 798,192 | +11.8% | 0.00% | 0.0% |
| Q4 2013 | $13,067,000 | -31.4% | 714,054 | +0.5% | 0.00% | -50.0% |
| Q3 2013 | $19,040,000 | +97.3% | 710,457 | +35.9% | 0.00% | +100.0% |
| Q2 2013 | $9,648,000 | – | 522,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,210,000 | 4.33% |
| DESTRIER CAPITAL MANAGEMENT LLC | 933,600 | $9,243,000 | 2.32% |
| SENZAR ASSET MANAGEMENT, LLC | 753,600 | $7,460,000 | 2.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,014,164 | $10,040,000 | 1.39% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 775,307 | $7,675,000 | 0.50% |
| Trellus Management Company, LLC | 50,000 | $495,000 | 0.42% |
| FNY Managed Accounts LLC | 14,000 | $138,600,000 | 0.42% |
| GENERAL AMERICAN INVESTORS CO INC | 449,475 | $4,450,000 | 0.36% |
| Baker Brothers Advisors | 2,778,654 | $27,509,000 | 0.35% |
| CQS Cayman LP | 550,000 | $5,445,000 | 0.32% |